National Health Act 1953 Amendment determination under section 84AF responsible persons (No. PB 64 of 2009) (Cth)
COMMONWEALTH OF AUSTRALIA
Instrument number PB 64 of 2009
Amendment determination under section 84AF of the National Health Act 1953
I, LINDA JACKSON, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under section 84AF of the National Health Act 1953.
Dated 6 July 2009
LINDA JACKSON
Assistant Secretary
Pharmaceutical Evaluation Branch
Department of Health and Ageing
Amendment determination – responsible persons
1 Commencement
This instrument commences on 1 August 2009.
2 Amendment of PB 115 of 2008
Schedule 1 amends PB 115 of 2008.
Schedule 1 Amendments
[1]Schedule 1, after item dealing with Amoxycillin with Clavulanic Acid in the form Powder for oral suspension containing 125 mg amoxycillin (as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75 mL (Clamoxyl)
insert in the columns in the order indicated:
| Amoxycillin with Clavulanic Acid | Powder for oral suspension containing 125 mg amoxycillin (as trihydrate) with 31.25 mg clavulanic acid (as potassium clavulanate) per 5 mL, 75 mL | Oral | Curam | Sandoz Pty Ltd | 60 075 449 553 |
[2]Schedule 1, after item dealing with Amoxycillin with Clavulanic Acid in the form Powder for oral suspension containing 400 mg amoxycillin (as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL (Clamoxyl Duo 400)
insert in the columns in the order indicated:
| Amoxycillin with Clavulanic Acid | Powder for oral suspension containing 400 mg amoxycillin (as trihydrate) with 57 mg clavulanic acid (as potassium clavulanate) per 5 mL, 60 mL | Oral | Curam Duo | Sandoz Pty Ltd | 60 075 449 553 |
| Amoxycillin with Clavulanic Acid | Tablet containing 500 mg amoxycillin (as trihydrate) with 125 mg clavulanic acid (as potassium clavulanate) | Oral | APO-Amoxycillin/ Clavulanic Acid 500/125 | Apotex Pty Ltd | 52 096 916 148 |
[3]Schedule 1, item dealing with Ampicillin in the form Powder for injection 1 g (as sodium) (Ibimicyn)
omit from the columns in the order indicated:
| Genepharm Pty Ltd | 68 118 734 795 |
and substitute:
| Specialised Therapeutics Australia Pty Ltd | 73 124 031 241 |
[4]Schedule 1, item dealing with Ampicillin in the form Powder for injection 500 mg (as sodium) (Ibimicyn)
omit from the columns in the order indicated:
| Genepharm Pty Ltd | 68 118 734 795 |
and substitute:
| Specialised Therapeutics Australia Pty Ltd | 73 124 031 241 |
[5]Schedule 1, after items dealing with Aripiprazole
insert in the columns in the order indicated:
| Arsenic | Injection concentrate containing arsenic trioxide 10 mg in 10 mL | Injection | Phenasen | Virgo Unit Trust | 77 695 661 635 |
[6]Schedule 1, after item dealing with Azithromycin in the form Powder for oral suspension 200 mg (as dihydrate) per 5 mL, 15 mL
insert in the columns in the order indicated:
| Azithromycin | Tablet 500 mg (as dihydrate) | Oral | Azithromycin Sandoz | Sandoz Pty Ltd | 60 075 449 553 |
[7]Schedule 1, after item dealing with Bimatoprost
insert in the columns in the order indicated:
| Bimatoprost with timolol | Eye drops 300 micrograms bimatoprost with timolol 5 mg (as maleate) per mL, 3 mL | Application to the eye | Ganfort 0.3/5 | Allergan Australia Pty Limited | 85 000 612 831 |
[8]Schedule 1, items dealing with Bisacodyl
omit from the columns in the order indicated:
| Bisacodyl | Suppositories 10 mg, 12 | Rectal | Fleet Laxative Suppositories | C.B. Fleet Co. (Aust.) Pty Ltd | 67 004 098 266 |
[9]Schedule 1, after item dealing with Bisoprolol in the form Tablet containing bisoprolol fumarate 10 mg
insert in the columns in the order indicated:
| Bisoprolol | Tablet containing bisoprolol fumarate 10 mg | Oral | Bisoprolol Sandoz | Sandoz Pty Ltd | 60 075 449 553 |
| Bisoprolol | Tablet containing bisoprolol fumarate 10 mg | Oral | Bispro 10 | Alphapharm Pty Ltd | 93 002 359 739 |
Schedule 1, after item dealing with Bisoprolol in the form Tablet containing bisoprolol fumarate 2.5 mg
insert in the columns in the order indicated:
| Bisoprolol | Tablet containing bisoprolol fumarate 2.5 mg | Oral | Bisoprolol Sandoz | Sandoz Pty Ltd | 60 075 449 553 |
| Bisoprolol | Tablet containing bisoprolol fumarate 2.5 mg | Oral | Bispro 2.5 | Alphapharm Pty Ltd | 93 002 359 739 |
Schedule 1, after item dealing with Bisoprolol in the form Tablet containing bisoprolol fumarate 5 mg
insert in the columns in the order indicated:
| Bisoprolol | Tablet containing bisoprolol fumarate 5 mg | Oral | Bisoprolol Sandoz | Sandoz Pty Ltd | 60 075 449 553 |
| Bisoprolol | Tablet containing bisoprolol fumarate 5 mg | Oral | Bispro 5 | Alphapharm Pty Ltd | 93 002 359 739 |
Schedule 1, after item dealing with Busulfan
insert in the columns in the order indicated:
| Cabergoline | Tablet 1 mg | Oral | Bergoline 1 | Sigma Pharmaceuticals (Australia) Pty Ltd | 88 004 118 594 |
Schedule 1, after item dealing with Cabergoline in the form Tablet
1 mg (Cabaser)
insert in the columns in the order indicated:
| Cabergoline | Tablet 2 mg | Oral | Bergoline 2 | Sigma Pharmaceuticals (Australia) Pty Ltd | 88 004 118 594 |
Schedule 1, after item dealing with Cabergoline in the form Tablet
500 micrograms
insert in the columns in the order indicated:
| Cabergoline | Tablet 500 micrograms | Oral | Tinexa | Sigma Pharmaceuticals (Australia) Pty Ltd | 88 004 118 594 |
Schedule 1, item dealing with Carvedilol in the form Tablet 12.5 mg (Dilasig 12.5)
omit from the columns in the order indicated:
| Sigma Pharmaceuticals (Australia) Pty Ltd | 88 004 118 594 |
and substitute:
| Fawns and McAllan Proprietary Limited | 16 004 296 066 |
Schedule 1, item dealing with Carvedilol in the form Tablet 12.5 mg (Vedilol 12.5)
omit from the columns in the order indicated:
| Spirit Pharmaceuticals Pty Ltd | 67 109 225 747 |
and substitute:
| Sigma Pharmaceuticals (Australia) Pty Ltd | 88 004 118 594 |
Schedule 1, item dealing with Carvedilol in the form Tablet 25 mg (Dilasig 25)
omit from the columns in the order indicated:
| Sigma Pharmaceuticals (Australia) Pty Ltd | 88 004 118 594 |
and substitute:
| Fawns and McAllan Proprietary Limited | 16 004 296 066 |
Schedule 1, item dealing with Carvedilol in the form Tablet 25 mg (Vedilol 25)
omit from the columns in the order indicated:
| Spirit Pharmaceuticals Pty Ltd | 67 109 225 747 |
and substitute:
| Sigma Pharmaceuticals (Australia) Pty Ltd | 88 004 118 594 |
Schedule 1, item dealing with Carvedilol in the form Tablet 3.125 mg (Dilasig 3.125)
omit from the columns in the order indicated:
| Sigma Pharmaceuticals (Australia) Pty Ltd | 88 004 118 594 |
and substitute:
| Fawns and McAllan Proprietary Limited | 16 004 296 066 |
Schedule 1, item dealing with Carvedilol in the form Tablet 3.125 mg (Vedilol 3.125)
omit from the columns in the order indicated:
| Spirit Pharmaceuticals Pty Ltd | 67 109 225 747 |
and substitute:
| Sigma Pharmaceuticals (Australia) Pty Ltd | 88 004 118 594 |
Schedule 1, item dealing with Carvedilol in the form Tablet 6.25 mg (Dilasig 6.25)
omit from the columns in the order indicated:
| Sigma Pharmaceuticals (Australia) Pty Ltd | 88 004 118 594 |
and substitute:
| Fawns and McAllan Proprietary Limited | 16 004 296 066 |
Schedule 1, item dealing with Carvedilol in the form Tablet 6.25mg (Vedilol 6.25)
omit from the columns in the order indicated:
| Spirit Pharmaceuticals Pty Ltd | 67 109 225 747 |
and substitute:
| Sigma Pharmaceuticals (Australia) Pty Ltd | 88 004 118 594 |
Schedule 1, omit item dealing with Chorionic Gonadotrophin in the form Injection set containing 3 ampoules powder for injection 500 units and 3 ampoules solvent 1 mL
Schedule 1, after item dealing with Citalopram in the form Tablet
10 mg (as hydrobromide)
insert in the columns in the order indicated:
| Citalopram | Tablet 20 mg (as hydrobromide) | Oral | APO-Citalopram | Apotex Pty Ltd | 52 096 916 148 |
Schedule 1, after item dealing with Clarithromycin in the form Powder for oral liquid 250 mg per 5 mL, 50 mL
insert in the columns in the order indicated:
| Clarithromycin | Tablet 250 mg | Oral | APO-Clarithromycin | Apotex Pty Ltd | 52 096 916 148 |
Schedule 1, after item dealing with Codeine
insert in the columns in the order indicated:
| Codeine with Paracetamol | Tablet containing codeine phosphate 30 mg with paracetamol 500 mg | Oral | APO-Paracetamol/ Codeine 500/30 | Apotex Pty Ltd | 52 096 916 148 |
Schedule 1, after item dealing with Escitalopram in the form Tablet
10 mg (as oxalate) (Esitalo)
insert in the columns in the order indicated:
| Escitalopram | Tablet 10 mg (as oxalate) | Oral | Lexam 10 | Sigma Pharmaceuticals (Australia) Pty Ltd | 88 004 118 594 |
Schedule 1, after item dealing with Escitalopram in the form Tablet
20 mg (as oxalate) (Esitalo)
insert in the columns in the order indicated:
| Escitalopram | Tablet 20 mg (as oxalate) | Oral | Lexam 20 | Sigma Pharmaceuticals (Australia) Pty Ltd | 88 004 118 594 |
Schedule 1, after item dealing with Essential amino acids formula with vitamins and minerals
insert in the columns in the order indicated:
| Etanercept | Injection 50 mg in 1 mL single use injection pen, 4 | Injection | Enbrel | Wyeth Australia Pty Limited | 16 000 296 211 |
Schedule 1, item dealing with Flucloxacillin in the form Powder for injection 1 g (as sodium) (Flubiclox)
omit from the columns in the order indicated:
| Genepharm Pty Ltd | 68 118 734 795 |
and substitute:
| Specialised Therapeutics Australia Pty Ltd | 73 124 031 241 |
Schedule 1, item dealing with Flucloxacillin in the form Powder for injection 500 mg (as sodium) (Flubiclox)
omit from the columns in the order indicated:
| Genepharm Pty Ltd | 68 118 734 795 |
and substitute:
| Specialised Therapeutics Australia Pty Ltd | 73 124 031 241 |
Schedule 1, after item dealing with Gemcitabine in the form Solution concentrate for I.V. infusion 200 mg (as hydrochloride) in 20 mL
insert in the columns in the order indicated:
| Gemcitabine | Solution concentrate for I.V. infusion 500 mg (as hydrochloride) in 50 mL | Injection | Gemcitabine Ebewe | InterPharma Pty Ltd | 19 099 877 899 |
Schedule 1, after item dealing with Glucagon
insert in the columns in the order indicated:
| Glucose | I.V. infusion 139 mmol (anhydrous) per 500 mL, 500 mL | Injection | B.Braun Australia Pty Ltd | B.Braun Australia Pty Ltd | 56 002 945 155 |
| Glucose | I.V. infusion 139 mmol (anhydrous) per 500 mL, 500 mL | Injection | Pharmatel Fresenius Kabi Pty Limited | Pharmatel Fresenius Kabi Pty Limited | 39 109 383 593 |
| Glucose | I.V. infusion 278 mmol (anhydrous) per 500 mL, 500 mL | Injection | Pharmatel Fresenius Kabi Pty Limited | Pharmatel Fresenius Kabi Pty Limited | 39 109 383 593 |
| Glucose | I.V. infusion 278 mmol (anhydrous) per L, 1 L | Injection | B.Braun Australia Pty Ltd | B.Braun Australia Pty Ltd | 56 002 945 155 |
Schedule 1, after item dealing with Glucose in the form I.V. infusion 278 mmol (anhydrous) per L, 1 L (Baxter Healthcare Pty Ltd)
insert in the columns in the order indicated:
| Glucose | I.V. infusion 69.5 mmol (anhydrous) per 250 mL, 250 mL | Injection | B.Braun Australia Pty Ltd | B.Braun Australia Pty Ltd | 56 002 945 155 |
Schedule 1, items dealing with Glucose Indicator—Blood
omit from the columns in the order indicated:
| Glucose Indicator—Blood | Electrode strips, 100 (TrueSense) | For external use | TrueSense | Abbott Australasia Pty Ltd | 95 000 180 389 |
Schedule 1, after item dealing with Glucose Indicator—Blood in the form Electrode strips, 50 (MWD Pen Sensor Strips)
insert in the columns in the order indicated:
| Glucose Indicator—Blood | Electrode strips, 50 (MyGlucoHealth) | For external use | MyGlucoHealth | Entra Health Systems Pty Ltd | 14 135 973 303 |
Schedule 1, after item dealing with Hexamine
insert in the columns in the order indicated:
| High fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate | Oral powder 300 g (KetoCal) | Oral | KetoCal | Nutricia Australia Pty Limited | 99 076 246 752 |
Schedule 1, after item dealing with Hypromellose in the form Eye drops 5 mg per mL, 15 mL
insert in the columns in the order indicated:
| Hypromellose | Oral gel 20 mg per g, 100 g | Oral application | Aquae Gel | Hamilton Pharmaceutical Pty Ltd | 93 008 204 635 |
Schedule 1, item dealing with Insulin Lispro in the form Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 (Humalog Pen)
omit from the column headed “Brand”:
Humalog Pen
and substitute:
Humalog KwikPen
Schedule 1, item dealing with Insulin Lispro with Insulin Lispro Protamine Suspension in the form Injections (human analogue), cartridges, 25 units-75 units per mL, 3 mL, 5 (Humalog Mix25 Pen)
omit from the column headed “Brand”:
Humalog Mix25 Pen
and substitute:
Humalog Mix25 KwikPen
Schedule 1, item dealing with Insulin Lispro with Insulin Lispro Protamine Suspension in the form Injections (human analogue), cartridges, 50 units-50 units per mL, 3 mL, 5 (Humalog Mix50 Pen)
omit from the column headed “Brand”:
Humalog Mix50 Pen
and substitute:
Humalog Mix50 KwikPen
Schedule 1, after item dealing with Lisinopril in the form Tablet 20 mg (Lisinopril Ranbaxy)
insert in the columns in the order indicated:
| Lisinopril | Tablet 20 mg | Oral | Lisinopril Sandoz | Sandoz Pty Ltd | 60 075 449 553 |
Schedule 1, after item dealing with Morphine in the form Tablet containing morphine sulfate 10 mg
insert in the columns in the order indicated:
| Morphine | Tablet containing morphine sulfate 10 mg (controlled release) | Oral | Momex SR 10 | Sigma Pharmaceuticals (Australia) Pty Ltd | 88 004 118 594 |
Schedule 1, after item dealing with Morphine in the form Tablet containing morphine sulfate 10 mg (controlled release) (MS Contin)
insert in the columns in the order indicated:
| Morphine | Tablet containing morphine sulfate 100 mg (controlled release) | Oral | Momex SR 100 | Sigma Pharmaceuticals (Australia) Pty Ltd | 88 004 118 594 |
Schedule 1, after item dealing with Morphine in the form Tablet containing morphine sulfate 30 mg
insert in the columns in the order indicated:
| Morphine | Tablet containing morphine sulfate 30 mg (controlled release) | Oral | Momex SR 30 | Sigma Pharmaceuticals (Australia) Pty Ltd | 88 004 118 594 |
Schedule 1, after item dealing with Morphine in the form Tablet containing morphine sulfate 5 mg (controlled release)
insert in the columns in the order indicated:
| Morphine | Tablet containing morphine sulfate 60 mg (controlled release) | Oral | Momex SR 60 | Sigma Pharmaceuticals (Australia) Pty Ltd | 88 004 118 594 |
Schedule 1, after item dealing with Nifedipine in the form Tablet 30 mg (controlled release) (Adefin XL 30)
insert in the columns in the order indicated:
| Nifedipine | Tablet 30 mg (controlled release) | Oral | APO-Nifedipine XR | Apotex Pty Ltd | 52 096 916 148 |
Schedule 1, after item dealing with Nifedipine in the form Tablet 60 mg (controlled release) (Adefin XL 60)
insert in the columns in the order indicated:
| Nifedipine | Tablet 60 mg (controlled release) | Oral | APO-Nifedipine XR | Apotex Pty Ltd | 52 096 916 148 |
Schedule 1, after item dealing with Oxybutynin in the form Tablet containing oxybutynin hydrochloride 5 mg (Oxybutynin Winthrop)
insert in the columns in the order indicated:
| Oxybutynin | Transdermal patches 36 mg, 8 | Transdermal | Oxytrol | Hospira Pty Limited | 13 107 058 328 |
Schedule 1, after item dealing with Paclitaxel in the form Solution concentrate for I.V. infusion 100 mg in 16.7 mL (Baxter Paclitaxel)
insert in the columns in the order indicated:
| Paclitaxel | Solution concentrate for I.V. infusion 100 mg in 16.7 mL | Injection | Paclitaxel Actavis | Generic Health Pty Ltd | 93 110 617 859 |
Schedule 1, after item dealing with Paclitaxel in the form Solution concentrate for I.V. infusion 150 mg in 25 mL (Anzatax)
insert in the columns in the order indicated:
| Paclitaxel | Solution concentrate for I.V. infusion 150 mg in 25 mL | Injection | Paclitaxel Actavis | Generic Health Pty Ltd | 93 110 617 859 |
Schedule 1, after item dealing with Paclitaxel in the form Solution concentrate for I.V. infusion 30 mg in 5 mL (Baxter Paclitaxel)
insert in the columns in the order indicated:
| Paclitaxel | Solution concentrate for I.V. infusion 30 mg in 5 mL | Injection | Paclitaxel Actavis | Generic Health Pty Ltd | 93 110 617 859 |
Schedule 1, after item dealing with Paclitaxel in the form Solution concentrate for I.V. infusion 300 mg in 50 mL (Baxter Paclitaxel)
insert in the columns in the order indicated:
| Paclitaxel | Solution concentrate for I.V. infusion 300 mg in 50 mL | Injection | Paclitaxel Actavis | Generic Health Pty Ltd | 93 110 617 859 |
Schedule 1, after item dealing with Paracetamol in the form Suppositories 500 mg, 24
insert in the columns in the order indicated:
| Paracetamol | Tablet 500 mg | Oral | APO-Paracetamol | Apotex Pty Ltd | 52 096 916 148 |
Schedule 1, items dealing with Paracetamol
omit from the columns in the order indicated:
| Paracetamol | Tablet 500 mg | Oral | Parmol | Sigma Pharmaceuticals (Australia) Pty Ltd | 88 004 118 594 |
Schedule 1, after item dealing with Paroxetine in the form Tablet
20 mg (as hydrochloride) (Paroxetine-DP)
insert in the columns in the order indicated:
| Paroxetine | Tablet 20 mg (as hydrochloride) | Oral | Paroxetine-GA | Ascent Pharmahealth Ltd | 52 107 340 367 |
Schedule 1, after items dealing with Pravastatin
insert in the columns in the order indicated:
| Praziquantel | Tablet 600 mg | Oral | Biltricide | Bayer Australia Ltd | 22 000 138 714 |
Schedule 1, after item dealing with Ramipril in the form Pack containing 7 tablets 2.5 mg, 21 tablets 5 mg and 10 capsules 10 mg
insert in the columns in the order indicated:
| Ramipril | Tablet 1.25 mg | Oral | APO-Ramipril | Apotex Pty Ltd | 52 096 916 148 |
| Ramipril | Tablet 1.25 mg | Oral | Chem mart Ramipril | Apotex Pty Ltd | 52 096 916 148 |
Schedule 1, after item dealing with Ramipril in the form Tablet 1.25 mg (Ramipril Winthrop)
insert in the columns in the order indicated:
| Ramipril | Tablet 1.25 mg | Oral | Terry White Chemists Ramipril | Apotex Pty Ltd | 52 096 916 148 |
Schedule 1, after item dealing with Ramipril in the form Tablet 1.25 mg (Tryzan Tabs 1.25)
insert in the columns in the order indicated:
| Ramipril | Tablet 10 mg | Oral | APO-Ramipril | Apotex Pty Ltd | 52 096 916 148 |
| Ramipril | Tablet 10 mg | Oral | Chem mart Ramipril | Apotex Pty Ltd | 52 096 916 148 |
Schedule 1, after item dealing with Ramipril in the form Tablet 10 mg (Ramipril Sandoz)
insert in the columns in the order indicated:
| Ramipril | Tablet 10 mg | Oral | Terry White Chemists Ramipril | Apotex Pty Ltd | 52 096 916 148 |
Schedule 1, after item dealing with Ramipril in the form Tablet 10 mg (Tryzan Tabs 10)
insert in the columns in the order indicated:
| Ramipril | Tablet 2.5 mg | Oral | APO-Ramipril | Apotex Pty Ltd | 52 096 916 148 |
| Ramipril | Tablet 2.5 mg | Oral | Chem mart Ramipril | Apotex Pty Ltd | 52 096 916 148 |
Schedule 1, after item dealing with Ramipril in the form Tablet 2.5 mg (Ramipril Winthrop)
insert in the columns in the order indicated:
| Ramipril | Tablet 2.5 mg | Oral | Terry White Chemists Ramipril | Apotex Pty Ltd | 52 096 916 148 |
Schedule 1, after item dealing with Ramipril in the form Tablet 2.5 mg (Tryzan Tabs 2.5)
insert in the columns in the order indicated:
| Ramipril | Tablet 5 mg | Oral | APO-Ramipril | Apotex Pty Ltd | 52 096 916 148 |
| Ramipril | Tablet 5 mg | Oral | Chem mart Ramipril | Apotex Pty Ltd | 52 096 916 148 |
Schedule 1, after item dealing with Ramipril in the form Tablet 5 mg (Ramipril Winthrop)
insert in the columns in the order indicated:
| Ramipril | Tablet 5 mg | Oral | Terry White Chemists Ramipril | Apotex Pty Ltd | 52 096 916 148 |
Schedule 1, after items dealing with Rituximab
insert in the columns in the order indicated:
| Rivaroxaban | Tablet 10 mg | Oral | Xarelto | Bayer Australia Ltd | 22 000 138 714 |
| Rivaroxaban | Tablet 10 mg, 15 | Oral | Xarelto | Bayer Australia Ltd | 22 000 138 714 |
| Rivaroxaban | Tablet 10 mg, 30 | Oral | Xarelto | Bayer Australia Ltd | 22 000 138 714 |
Schedule 1, after items dealing with Sitagliptin
insert in the columns in the order indicated:
| Sitagliptin with metformin | Tablet containing 50 mg sitagliptin (as phosphate monohydrate) with 1000 mg metformin hydrochloride | Oral | Janumet | Merck Sharp & Dohme (Australia) Pty Ltd | 14 000 173 508 |
| Sitagliptin with metformin | Tablet containing 50 mg sitagliptin (as phosphate monohydrate) with 500 mg metformin hydrochloride | Oral | Janumet | Merck Sharp & Dohme (Australia) Pty Ltd | 14 000 173 508 |
| Sitagliptin with metformin | Tablet containing 50 mg sitagliptin (as phosphate monohydrate) with 850 mg metformin hydrochloride | Oral | Janumet | Merck Sharp & Dohme (Australia) Pty Ltd | 14 000 173 508 |
Schedule 1, after item dealing with Sodium Acid Phosphate
insert in the columns in the order indicated:
| Sodium Chloride | I.V. infusion 154 mmol per L, 1 L | Injection | B.Braun Australia Pty Ltd | B.Braun Australia Pty Ltd | 56 002 945 155 |
Schedule 1, after item dealing with Sodium Chloride in the form I.V. infusion 154 mmol per L, 1 L (Baxter Healthcare Pty Ltd)
insert in the columns in the order indicated:
| Sodium Chloride | I.V. infusion 38.5 mmol per 250 mL, 250 mL | Injection | B.Braun Australia Pty Ltd | B.Braun Australia Pty Ltd | 56 002 945 155 |
Schedule 1, after item dealing with Sodium Chloride in the form I.V. infusion 513 mmol per L, 1 L
insert in the columns in the order indicated:
| Sodium Chloride | I.V. infusion 77 mmol per 500 mL, 500 mL | Injection | B.Braun Australia Pty Ltd | B.Braun Australia Pty Ltd | 56 002 945 155 |
| Sodium Chloride | I.V. infusion 77 mmol per 500 mL, 500 mL | Injection | Pharmatel Fresenius Kabi Pty Limited | Pharmatel Fresenius Kabi Pty Limited | 39 109 383 593 |
Schedule 1, after item dealing with Sodium Chloride with Glucose in the form I.V. infusion 39 mmol-69 mmol (anhydrous) per 500 mL,
500 mL
insert in the columns in the order indicated:
| Sodium Lactate Compound | I.V. infusion containing approximately 131 mmol sodium (as lactate and chloride), 5 mmol potassium (as chloride), 2 mmol calcium (as chloride), 29 mmol bicarbonate (as lactate) and 111 mmol chloride per L, 1 L | Injection | B.Braun Australia Pty Ltd | B.Braun Australia Pty Ltd | 56 002 945 155 |
Schedule 1, after item dealing with Sodium Lactate Compound in the form I.V. infusion containing approximately 65 mmol sodium (as lactate and chloride), 2.7 mmol potassium (as chloride), 0.9 mmol calcium (as chloride), 14 mmol bicarbonate (as lactate) and 56 mmol chloride per 500 mL, 500 mL
insert in the columns in the order indicated:
| Sodium Lactate Compound | I.V. infusion containing approximately 65 mmol sodium (as lactate and chloride), 2.7 mmol potassium (as chloride), 0.9 mmol calcium (as chloride), 14 mmol bicarbonate (as lactate) and 56 mmol chloride per 500 mL, 500 mL | Injection | Pharmatel Fresenius Kabi Pty Limited | Pharmatel Fresenius Kabi Pty Limited | 39 109 383 593 |
Schedule 1, after items dealing with Sotalol
insert in the columns in the order indicated:
| Soy lecithin | Eye spray 10 mg per mL, 10 mL | Application | tearsagain | Bio Revive Pty Ltd | 58 097 360 417 |
Schedule 1, after items dealing with Telmisartan with Hydrochlorothiazide
insert in the columns in the order indicated:
| Temazepam | Tablet 10 mg | Oral | APO-Temazepam | Apotex Pty Ltd | 52 096 916 148 |
Schedule 1, item dealing with Teriparatide
omit from the column headed “Form”:
3 mL
and substitute:
2.4 mL
Schedule 1, after items dealing with Vinorelbine
insert in the columns in the order indicated:
| Voriconazole | Powder for oral suspension 40 mg per mL, 70 mL | Oral | Vfend | Pfizer Australia Pty Ltd | 50 008 422 348 |
0
0
0